Hepatitis E virus

Reviews in Medical Virology

Volumn 13, Issue 3, 2003, Pages 145-154

  Emerson, Suzanne U ^a,b   Purcell, Robert H ^b  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b MSC 8009 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; CAPSID PROTEIN; EPITOPE; HEPATITIS E VACCINE; HEPATITIS VACCINE; MONOCLONAL ANTIBODY; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ANIMAL MODEL; CLINICAL TRIAL; ENDEMIC DISEASE; GENE OVEREXPRESSION; GENOTYPE; HEPATITIS E; HEPATITIS E VIRUS; HUMAN; IMMUNOPROPHYLAXIS; NEPAL; NONHUMAN; OPEN READING FRAME; PHASE 2 CLINICAL TRIAL; PHASE 3 CLINICAL TRIAL; PHYLOGENY; PROTEIN EXPRESSION; REVIEW; RNA VIRUS; SEROLOGY; VACCINATION; VIRUS CAPSID; VIRUS HEPATITIS; VIRUS TRANSMISSION; VIRUS VIRULENCE;

ANIMALS; GENOME, VIRAL; HEPATITIS E; HEPATITIS E VIRUS; HUMANS; OPEN READING FRAMES; PHYLOGENY; VIRAL VACCINES; WORLD HEALTH;

EID: 0038706105     PISSN: 10529276     EISSN: None     Source Type: Journal    
DOI: 10.1002/rmv.384     Document Type: Review

References (52)

1. Purcell RH, Emerson SU. Hepatitis E virus. In Fields Virology, Knipe DM, Howley PM, Griffin DE, et al. (eds). Lippincott, Williams and Wilkins: Philadelphia, 2001; 3051-3061.
2. Schlauder GG, Mushahwar IK. Genetic heterogeneity of hepatitis E virus. J Med Virol 2001; 65: 282-292.
3. Balayan MS, Andjaparidze AG, Savinskaya SS, et al. Evidence for a virus in non-A, non-B hepatitis transmitted via the fecal-oral route. Intervirology 1983; 20: 23-31.
4. Tam AW, Smith MM, Guerra ME, et al. Hepatitis E virus (HEV): molecular cloning and sequencing of the full-length viral genome. Virology 1991; 185: 120-131.
5. Koonin EV, Gorbalenya AE, Purdy MA, et al. Computer-assisted assignment of functional domains in the nonstructural polyprotein of hepatitis E virus: delineation of an additional group of positive-strand RNA plant and animal viruses. Proc Natl Acad Sci USA 1992; 89: 8259-8263.
6. Berke T, Matson DO. Reclassification of the Caliciviridae into distinct genera and exclusion of hepatitis E virus from the family on the basis of comparative phylogenetic analysis. Arch Virol 2000; 145: 1421-1436.
7. Purcell RH, Emerson SU. Animal models of hepatitis A and E. ILAR J 2001; 42: 161-177.
8. Tsarev SA, Tsareva TS, Emerson SU, et al. Infectivity titration of a prototype strain of hepatitis E virus in cynomolgus monkeys. J Med Virol 1994; 43: 135-142.
9. Arankalle VA, Chadha MS, Banerjee K, et al. Hepatitis E virus infection in pregnant rhesus monkeys. Indian J Med Res 1993; 97: 4-8.
10. Tsarev SA, Tsareva TS, Emerson SU, et al. Experimental hepatitis E in pregnant rhesus monkeys: failure to transmit hepatitis E virus (HEV) to offspring and evidence of naturally acquired antibodies to HEV. J Infect Dis 1995; 172: 31-37.
11. Arankalle VA, Tsarev SA, Chadha MS, et al. Age specific prevalence of antibodies to hepatitis A and E viruses in Pune, India, 1982 and 1992. J Infect Dis 1995; 171: 447-450.
12. Fix AD, Abdel-Hamid M, Purcell RH, et al. Prevalence of antibodies to hepatitis E virus in rural Egyptian communities. Am J Trop Med Hyg 2000; 62: 519-523.
13. Thomas DL, Yarbough GH, Vlahov D, et al. Seroreactivity to hepatitis E virus in areas where the disease is not endemic. J Clin Microbiol 1997; 35: 1244-1247.
14. Mast EE, Alter MJ, Holland PV, et al. Evaluation of assays for antibody to hepatitis E virus by a serum panel. Hepatitis E Virus Antibody Serum Panel Evaluation Group. Hepatology 1998; 27: 857-861.
15. Balayan MS, Usmanov RK, Zamyatina NA, et al. Brief report: experimental hepatitis E infection in domestic pigs. J Med Virol 1990; 32: 59-59.
16. Usmanov RK, Balaian MS, Dvoinikova OV, et al. Experimental infection of lambs with hepatitis E virus. Vopr Virusol 1994; 39: 165-168.
17. Meng X-J, Halbur PG, Haynes JS, et al. Experimental infection of pigs with the newly identified swine hepatitis E virus (swine HEV), but not with human strains of HEV. Arch Virol 1998; 143: 1405-1415.
18. Meng X-J, Purcell RH, Halbur PG, et al. A novel virus in swine is closely related to the human hepatitis E virus. Proc Natl Acad Sci USA 1997; 94: 9860-9865.
19. Erker JC, Desai SM, Schlauder GG, et al. A hepatitis E virus variant from the United States: molecular characterization and transmission in cynomolgus macaques. J Gen Virol 1999; 80: 681-690.
20. Meng X-J, Halbur PH, Shapiro MS, et al. Genetic and experimental evidence for cross-species infection by swine hepatitis E virus. J Virol 1998; 72: 9714-9721.
21. Hsieh SY, Meng XJ, Wu YH, et al. Identity of a novel swine hepatitis E virus in Taiwan forming a monophyletic group with Taiwan isolates of human hepatitis E virus. J Clin Microbiol 1999; 37: 3828-3834.
22. Drobeniuc J, Favorov MO, Shapiro CN, et al. Hepatitis E virus antibody prevalence among persons who work with swine. J Infect Dis 2001; 184: 1594-1597.
23. Meng XJ, Wiseman B, Elvinger F, et al. Prevalence of antibodies to hepatitis E virus in veterinarians working with swine and in normal blood donors in the United States and other countries. J Clin Microbiol 2002; 40: 117-122.
24. Arankalle VA, Chobe LP, Joshi MV, et al. Human and swine hepatitis E viruses from Western India belong to different genotypes. J Hepatol 2002; 36: 417-425.
25. Halbur PG, Kasorndorkbua C, Gilbert C, et al. Comparative pathogenesis of infection of pigs with hepatitis E viruses recovered from a pig and a human. J Clin Microbiol 2000; 39: 918-923.
26. Karetnyi YV, Dzhumalieva DI, Usmanov RK, et al. Probable involvement of rodents in the spread of viral hepatitis E. Zh Microbiol Epidemiol Immunobiol 1993; 4: 52-56.
27. Maneerat Y, Clayson ET, Myint KS, et al. Experimental infection of the laboratory rat with hepatitis E virus. J Med Virol 1996; 48: 121-128.
28. Haqshenas G, Shivaprasad HL, Woolcock PR, et al. Genetic identification and characterization of a novel virus related to human hepatitis E virus from chickens with hepatitis-splenomegaly syndrome in the United States. J Gen Virol 2001; 82: 2449-2462.
29. Ropp SL, Tam AW, Beames B, et al. Expression of the hepatitis E virus ORF1. Arch Virol 2000; 145: 1321-1337.
30. Ansari IH, Nanda SK, Durgapal H, et al. Cloning, sequencing, and expression of the hepatitis E virus (HEV) nonstructural open reading frame 1 (ORF1). J Med Virol 2000; 60: 275-283.
31. Kabrane-Lazizi Y, Meng X-J, Purcell RH, et al. Evidence that the genomic RNA of hepatitis E virus is capped. J Virol 1999; 73: 8848-8850.
32. Zhang M, Purcell RH, Emerson SU. Identification of the 5′ terminal sequence of the SAR-55 and MEX-14 strains of hepatitis E virus and confirmation that the genome is capped. J Med Virol 2001; 65: 293-295.
33. Magden J, Takeda N, Li T, et al. Virus-specific mRNA capping enzyme encoded by hepatitis E virus. J Virol 2001; 75: 6249-6255.
34. Agrawal S, Gupta D, Panda SK. The 3′ end of hepatitis E virus (HEV) genome binds specifically to the viral RNA-dependent RNA polymerase (RdRp). Virology 2001; 282: 87-101.
35. Emerson SU, Zhang M, Meng XJ, et al. Recombinant hepatitis E virus genomes infectious for primates: importance of capping and discovery of a cis-reactive element. Proc Natl Acad Sci USA 2001; 98: 15270-15275.
36. Zafrullah M, Ozdener MH, Kumar R, et al. Mutational analysis of glycosylation, membrane translocation, and cell surface expression of the hepatitis E virus ORF2 protein. J Virol 1999; 73: 4074-4082.
37. Robinson RA, Burgess WH, Emerson SU, et al. Structural characterization of recombinant hepatitis E virus ORF2 proteins in baculovirus-infected insect cells. Protein Expr Purif 1998; 12: 75-84.
38. Li T, Yamakawa Y, Suzuki K, et al. Expression and self-assembly of empty virus-like particles of hepatitis E virus. J Virol 1997; 71: 7207-7213.
39. Xing L, Kato K, Li T, et al. Recombinant hepatitis E capsid protein self-assembles into a dual-domain T = 1 particle presenting native virus epitopes. Virology 1999; 265: 35-45.
40. Zafrullah M, Ozdener MH, Panda SK, et al. The ORF3 protein of hepatitis E virus is a phosphoprotein that associates with the cytoskeleton. J Virol 1997; 71: 9045-9053.
41. Korkaya H, Jameel S, Gupta D, et al. The ORF3 protein of hepatitis E virus binds to Src homology 3 domains and activates MAPK. J Biol Chem 2001; 276: 42389-42400.
42. Tyagi S, Korkaya H, Zafrullah M, et al. The phosphorylated form of the ORF3 protein of hepatitis E virus interacts with its non-glycosylated form of the major capsid protein, ORF2. J Biol Chem 2002; 277: 22759-22767.
43. Bryan JP, Tsarev SA, Iqbal M, et al. Epidemic hepatitis E in Pakistan: patterns of serologic response and evidence that the antibody to hepatitis E virus protects against disease. J Infect Dis 1994; 170: 517-521.
44. Tsarev SA, Tsareva TS, Emerson SU, et al. Successful passive and active immunization of cynomolgus monkeys against hepatitis E. Proc Natl Acad Sci USA 1994; 91: 10198-10202.
45. Emerson SU, Purcell RH. Recombinant vaccines for hepatitis E. Trends Mol Med 2001; 7: 462-466.
46. Purdy MA, McCaustland KA, Krawczynski K, et al. Preliminary evidence that a trpE-HEV fusion protein protects cynomolgus macaques against challenge with wild-type hepatitis E virus (HEV). J Med Virol 1993; 41: 90-94.
47. Tsarev SA, Tsareva TS, Emerson SU, et al. Recombinant vaccine against hepatitis E: dose response and protection against heterologous challenge. Vaccine 1997; 15: 1834-1838.
48. Fuerst TR, Yarbough PO, Zhang Y, et al. Prevention of hepatitis E using a novel ORF-2 subunit vaccine. In Enterically Transmitted Hepatitis Viruses, Buisson Y, Coursaget P, Kane M (eds). Joue-les-Tours, France: Simarre, 1996; 384-392.
49. Schofield DJ, Glamann J, Emerson SU, et al. Identification by phage display and characterization of two neutralizing chimpanzee monoclonal antibodies to the hepatitis E virus capsid protein. J Virol 2000; 74-5548-5555.
50. Meng J, Dai X, Chang JC, et al. Identification and characterization of the neutralization epitope(s) of the hepatitis E virus. Virology 2001; 288: 203-211.
51. Zhang M, Emerson SU, Nguyen H, et al. Immunogenicity and protective efficacy of a vaccine prepared from 53 kDa truncated hepatitis E virus capsid protein expressed in insect cells. Vaccine 2002; 20: 853-857.
52. Zhang M, Emerson SU, Nguyen H, et al. Recombinant vaccine against hepatitis E: duration of protective immunity in rhesus macaques. Vaccine 2002; 20: 3285-3291.